AlphaGalileo is a service for the media.
Journalists should register for free access to embargoed
news and press office contact information.
Please register view details
Please register to view contact details
Please log in or register to view articles older than 3 months
This item is under embargo and is only visible to journalists
Bookmark this item in My Area
This item is bookmarked
Add comments to this news release
Kyoto-Osaka team uses hiPSCs to repair myocardial infarctions in rats
The creation of cardiac tissue-like constructs could offer an effective and convenient “woundplast” for repairing myocardial infarction.
Researchers from Kyoto University iCeMS and Osaka University have made biodegradable aligned nanofibers as a scaffold for culturing cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs). These CMs form myofibril-aligned, multi-layered and 3D-organized Cardiac Tissue-Like Constructs (CTLCs), which show robust drug response and may be readily used for repair of injured rat hearts with myocardial infarctions.
Researchers from the Institute for Integrated Cell-Material Sciences (iCeMS) of Kyoto University and the Department of Cardiovascular Surgery of Osaka University have developed effective and convenient Cardiac Tissue-Like Constructs (CTLCs) for repairing myocardial infarctions.
Cardiovascular diseases such as infarctions are the leading cause of death globally. A seriously injured heart cannot recover by itself, and heart transplants are the only effective treatment. However, the waiting list for transplants is extremely long. Previous researchers have also used cell transplant technologies to repair injured hearts, but these used CMs organized in two dimensions with a random, myofibril structure, which is different from natural heart tissue.
Dr. Li Liu and Prof. Yong Chen of iCeMS, together with Prof. Yoshiki Sawa of Osaka University and colleagues, selected a PLGA material approved by the FDA, and prepared biodegradable, aligned nanofibers for culturing CMs derived from hiPSCs, successfully creating organized and functional CTLCs.
They found that the CMs infiltrated and enveloped the nanofibers, showing elongation and high organization with upregulated expression of cardiac markers. Their CTLCs demonstrated more robust drug response compared with 2D CMs.
The team also used the CTLCs to simulate the repairing of disconnected and arrhythmia CMs. When used to repair injured rat hearts, the CTLCs showed excellent operability leading to favorable heart function recovery.
Future studies are now being planned to use CTLCs to repair injured hearts of larger animals, before advancing to clinical applications.
Article: Human Pluripotent Stem Cell-Derived Cardiac Tissue-Like Constructs for Repairing of the Infarcted Myocardium
Journal: Stem Cell Reports
Authors: Junjun Li, Itsunari Minami, Motoko Shiozaki, Leqian Yu, Shin Yajima, Shigeru Miyagawa, Yuji Shiba, Nobuhiro Morone, Satsuki Fukushima, Momoko Yoshioka, Sisi Li, Jing Qiao, Xin Li, Lin Wang, Hidetoshi Kotera, Norio Nakatsuji, Yoshiki Sawa, Yong Chen, and Li Liu
This item has been withdrawn. Registered users can contact the publishing organisation for further details by logging in